WIT Pharma

Marketing Strategy

We help you rebuild the portfolio in time and capture vacated niches: from a market-entry strategy for Russia & the CIS to pricing models and lifecycle management.

Who it's for

  • Companies launching a new product or portfolio in Russia & the CIS
  • Generic and biosimilar manufacturers that need a pricing and positioning strategy
  • Players targeting niches vacated after competitors' exit

What you get

Market entry strategy

Niche analysis, modelling and sales forecasting for Russia & the CIS.

Portfolio management

Portfolio rebuild and lifecycle management for the new market structure.

Pricing model

Pricing and positioning, including for generics and biosimilars.

Competitive intelligence

Competitor strategy analysis, launch monitoring and scenario modelling.

Niche capture strategy

Prioritizing niches vacated after players' exit or reduced presence.

How we work

  1. 01

    Market & portfolio diagnostics

    2-3 weeks

    Assessing positions, niches and the competitive field in the target segment.

  2. 02

    Scenarios & modelling

    3-4 weeks

    Sales forecasting, pricing scenarios and niche risk assessment.

  3. 03

    Strategy & plan

    2-3 weeks

    Setting priorities, a promotion model and a market-entry roadmap.

  4. 04

    Launch support

    per project

    Implementation support and adjustments based on market feedback.

Project example

International pharma · hospital segment

Objective. Market-entry strategy for a company with a hospital-product portfolio entering Russia.

What we did. Shaped the portfolio, developed promotion models and a sales forecast, and defined priority niches.

Outcome. The client received a substantiated market-entry roadmap with product prioritization.

Let's discuss your case

We'll propose the best format and timeline for your product.

Discuss a project

Other services

Market Research & HTA→Market Access→GR & Regulatory Environment→Registration→Event Management→